查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2025063

血液採集市場規模、佔有率、趨勢和預測：按產品、應用、最終用途和地區分類，2026-2034年

Blood Collection Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血液採集市場規模為76億美元。展望未來，IMARC Group預測，該市場將以3.87%的複合年成長率從2026年成長至2034年，到2034年達到107億美元。目前，北美市場主導地位，預計2025年將佔據41.2%的市場。全球市場擴張的原因包括：公眾醫療保健需求的成長、對價格合理且準確的診斷測試需求的增加，以及血液採集技術的不斷進步。

市場的主要驅動力是糖尿病、癌症和心血管疾病等慢性病的盛行率上升，這些疾病需要頻繁的血液檢測和監測。醫療基礎設施投資的增加，尤其是在新興經濟體，以及對先進診斷技術日益成長的需求，也促進了市場成長。捐血宣傳活動的增加和對血液短缺問題的宣傳也對需求產生了積極影響。血液採集設備的技術進步，例如微創技術，提高了患者的舒適度和安全性，加速了其普及應用。此外，全球人口老化、外科手術數量的增加以及個人化醫療的推廣，也推動了對血液採集服務的需求。監管支持和對研究及醫療創新的資金投入也進一步促進了市場擴張。

美國作為重要的區域市場脫穎而出，其主要驅動力是慢性病（包括糖尿病、癌症和心血管疾病）盛行率的不斷上升。這使得頻繁的血液檢測和監測變得必不可少。根據美國國家慢性病預防與健康促進中心 (NCCDPHP) 2024 年的報告，約有 1.29 億美國人患有一種或多種主要慢性病，其中 42% 的人患有兩種或兩種以上，12% 的人患有五種或五種以上。十大死因中有五種與可預防和可治療的慢性病密切相關。慢性病占美國醫療保健支出的 90%，每年高達 4.1 兆美元，而且其盛行率在過去 20 年中持續上升。全國範圍內完善的醫療保健基礎設施和先進的醫療技術正在推動高效血液採集系統的創新和應用。在政府計劃和非營利宣傳活動的支持下，人們對捐血重要性的認知不斷提高，這進一步促進了市場成長。尤其是在老齡化社會中，外科手術數量的增加，以及對疾病早期檢測和個人化醫療的日益重視，都大大促進了整體市場需求。

血液採集市場趨勢：

慢性病增多導致手術數量增加

全球血液採集市場正經歷顯著成長，主要受醫院手術量（包括剖腹產和複雜手術）的增加所推動。根據美國國立衛生研究院 (NIH) 數據顯示，印度剖腹產率從 2016 年的 17.2% 上升至 2021 年的 21.5%，凸顯了血液製品需求的成長。此外，久坐不動的生活方式和慢性疾病的增加也提高了定期體檢和血液檢測的需求。例如，英國每年報告新增癌症病例超過 38.5 萬例，強調了血液收集在疾病診斷中的重要性。這一趨勢表明，隨著非傳染性疾病負擔的加重，血液製品在治療和診斷中的重要性日益凸顯，從而推動了市場成長。

政府的各項措施和宣導活動旨在鼓勵捐血

全球各國政府實施的各項措施在推動捐血市場成長方面發揮著至關重要的作用。目前正在進行的各種宣傳活動旨在提高公眾對捐血必要性的認知，這對市場產生了積極影響。這些努力鼓勵自願捐血，並確保血液及相關成分的充足供應，以滿足醫療需求。公共衛生政策強調定期捐血對於挽救生命的重要性，並倡導以社區為基礎的醫療服務文化。在這方面，專注於緊急捐血、慢性病管理和災害應變的宣傳活動正在填補供應鏈缺口，尤其是在醫療服務匱乏的地區。這些政府措施確保了血液資源的永續供應，不僅滿足日常需求，也滿足緊急情況的需求，從而促進了全球捐血市場的成長。

正在革新血液採集的技術進步

技術創新正在透過提高效率和患者舒適度來改變血液採集市場。例如，用於糖尿病和糖尿病前期患者糖化血紅蛋白 (HbA1c) 檢測的按鈕式血液採集系統。這些創新縮短了檢體採集時間，減輕了患者的不適感，並提高了診斷準確性。自動化技術的進步使得一些血液採集系統能夠與診斷平台整合，從而實現無縫的即時數據傳輸。此外，這些技術滿足了預防醫學和個人化醫療日益成長的需求，在這些領域，快速且準確的診斷至關重要。減少錯誤和提高工作流程效率的技術進步也在推動先進血液採集工具的普及。大量的研發活動正在推動市場對滿足現代醫療保健系統不斷變化的需求的創新產品的追求。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血液採集市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 針頭和注射器
  • 採血管
    • 主要部分
      • 血清分離
      • EDTA
      • 肝素
      • 血漿分離
  • 血袋
  • 其他

第7章 市場區隔：依應用領域分類

  • 診斷
  • 治療

第8章 市場區隔：依最終用途分類

  • 醫院
  • 診斷中心
  • 血庫
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • FL MEDICAL srl
    • Greiner AG
    • Haemonetics Corporation
    • McKesson Corporation
    • Medtronic plc
    • Nipro Corporation
    • Qiagen NV
    • Quest Diagnostics
    • Sarstedt AG & Co. KG
    • Terumo Corporation
Product Code: SR112026A4975

The global blood collection market size was valued at USD 7.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 10.7 Billion by 2034, exhibiting a CAGR of 3.87% during 2026-2034. North America currently dominates the market, holding a significant market share of 41.2% in 2025. The global market is expanding due to the increasing healthcare needs among the masses, the rising demand for affordable and precise diagnostic tests, and continual advancements in collection technologies.

The market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require frequent blood testing and monitoring. Increasing healthcare infrastructure investments, particularly in emerging economies, and growing demand for advanced diagnostic techniques also contribute to the market growth. The increasing blood donation campaigns and awareness programs against blood shortages are positively influencing the demand. Technological advancement in blood collection devices, such as minimally invasive techniques, enhances patient comfort and safety, which in turn promotes adoption. In addition, the growing geriatric population across the globe and the increasing surgical procedures and personalized medicine are enhancing the requirement for blood collection services. Regulatory support and funding for research and healthcare innovations are further driving market expansion.

The United States stands out as a key regional market, primarily driven by the rising prevalence of chronic diseases, including diabetes, cancer, and cardiovascular conditions among the population, necessitating frequent blood diagnostics and monitoring. According to a 2024 research report by the National Center for Chronic Disease Prevention and Health Promotion, about 129 million Americans have one or more major chronic conditions, of whom 42% have two or more, and 12% have five or more. Five of the top 10 leading causes of death are strongly related to preventable and treatable chronic conditions. Chronic diseases account for 90% of the annual USD 4.1 Trillion U.S. health care costs, and their prevalence has been increasing steadily for the past two decades. The well-established healthcare infrastructure across the country with advanced medical technologies are driving innovation and adoption of efficient blood collection systems. Increased awareness regarding the importance of blood donations, supported by government initiatives and nonprofit campaigns, is further fueling the market growth. Rising surgical procedures, especially in aging population, coupled with the growing emphasis on early disease detection and personalized medicine, are contributing significantly to overall market demand.

BLOOD COLLECTION MARKET TRENDS:

Rising Number of Surgeries Amid Chronic Disease Growth

The global blood collection market is witnessing significant growth driven by the rising number of surgical procedures in hospitals, such as C-sections and complex surgeries. According to the National Institutes of Health (NIH), the rate of C-sections in India rose from 17.2% in 2016 to 21.5% in 2021, highlighting the growing demand for blood collection products. Besides, the diseases caused by sedentary lifestyles and chronic diseases are also increasing, thereby creating a requirement for frequent health checkups and blood tests. For example, in the UK, over 385,000 new cancer cases are reported every year, thereby emphasizing the significance of blood collection in disease diagnosis. This pattern indicates that the importance of blood collection products in both curative and diagnostic healthcare is increasing with the growing burden of non-communicable diseases, which is also propelling the market.

Government Initiatives and Awareness Programs Bolstering Blood Donation

Favorable government initiatives across the globe are playing a crucial role in stimulating the growth of the blood collection market. Various campaigns are being initiated to spread awareness about the need for blood donation, which is positively influencing the market. This initiative promotes voluntary donations and ensures adequate blood and related components for medical requirements. Public health initiatives are promoting the lifesaving capability of routine blood donation, creating a culture of community-based care. In this regard, through campaigns that focus on blood collection for emergencies, and management of chronic diseases, and disasters, the programs are able to fill gaps in supply chains, especially in the underserved areas. Such initiatives by governments are fueling the global growth of the market with sustainable flows of blood resources for routine as well as critical applications.

Technological Advancements Revolutionizing Blood Collection

Technological innovations are transforming the blood collection market by enhancing efficiency and patient comfort. For instance, the push-button blood collection system for HbA1c testing in diabetic and prediabetic patients. These innovations reduce sample collection time, decrease patient discomfort, and improve diagnostic accuracy. As a result of advancements in automation, several blood collection systems integrate with diagnostic platforms for a seamless transfer of data in real-time. In addition, these technologies address a growing need for preventive care and personalized medicine, as quick and precise diagnostics serve as an important factor for such practices. In addition, advancements that reduce errors and increase workflow efficiency are increasing the adoption of advanced blood collection tools. Extensive research and development (R&D) activities are impelling the market for innovative products that serve to meet the changing demands of modern healthcare systems.

BLOOD COLLECTION INDUSTRY SEGMENTATION:

Analysis by Product:

  • Needles and Syringes
  • Blood Collection Tubes
    • Serum-separating
    • EDTA
    • Heparin
    • Plasma-separating
  • Blood Bags
  • Others

Needles and syringes stand as the largest component in 2025, holding around 29.2% of the market. Needles and syringes are the leading products across the globe in terms of market share as they find extensive application in healthcare institutions. They are used to carry out blood sampling, transfusion, and diagnostic procedures. They play an important role in a multitude of medical procedures such as carrying out routine blood tests and emergency care and managing long-term diseases such as diabetes, and cancer. They are preferred by medical personnel due to their reliability and ease of use along with being cost-effective. Apart from these, improvements in the technology used in needles include ultra-slim needles and safety-engineered devices, that aid in lowering the risks for needlestick injuries. Increased rates of chronic conditions, an increasing rate of surgical intervention, and more thrust toward preventive care are creating demand for needles and syringes.

Analysis by Application:

  • Diagnostics
  • Treatment

Diagnostics leads the market with around 66.7% of market share in 2025. The largest product segment is diagnostics in the global blood collection market, led by a rise in chronic diseases and the resultant increase in the demand for early and accurate diagnosis of these diseases. In modern medicine, blood diagnostics help identify a variety of conditions including cancer, diabetes, cardiovascular and infectious diseases. The increasing trend of regular health check-ups, which are being increasingly conducted to check lifestyle-related conditions, is also increasing the demand for diagnostic tools. Technological developments, including automated analyzers and rapid diagnostic kits, are enhancing the speed and accuracy of blood tests and are strengthening their dominance in the market.

Analysis by End Use:

  • Hospitals
  • Diagnostics Centers
  • Blood Banks
  • Others

Hospitals lead the market with around 37.2% of market share in 2025. Hospitals constitute the largest percentage in the world market as it performs most of the diagnostic and therapeutic procedures in-house. A medical center primarily for surgery, trauma, chronic conditions, and emergency interventions requires blood collection products to diagnose conditions as promptly as possible and to treat the patients correctly. Increasing surgical procedures involving complicated organ transplantations and cancer surgery are expanding the requirement for blood collection solutions. Hospitals also act as important centers for blood banks and transfusion services; therefore, they play a key role in the supply chain of blood and blood components. Additionally, the rising prevalence of chronic diseases and lifestyle-related diseases also calls for regular testing of blood in hospital labs, thus consolidating its position in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.2%. North America accounts for the largest share of the market on account of its well-developed healthcare infrastructure, higher incidence of chronic diseases, and increasing penetration of advanced diagnostic technologies. High lifestyle-related disorders such as diabetes, cardiovascular diseases, and cancer further result in increased demand for blood collection products in the region. The increasing number of surgical procedures, coupled with the strong blood donation culture in the region, supports the demand for efficient blood collection solutions. Government campaigns encouraging blood donation and high regulatory standards ensure the quality and safety of blood collection processes, thereby contributing to market growth. Furthermore, technological advancement in North America leads it to the forefront of innovative practices.

KEY REGIONAL TAKEAWAYS:

UNITED STATES BLOOD COLLECTION MARKET ANALYSIS

In 2025, United States accounted for 82.50% of the North America blood collection market. The blood collection market in the United States is expanding as healthcare providers are adopting advanced technologies to enhance their diagnostic capabilities. Hospitals, diagnostic centers, and clinics focus on improving the efficiency and accuracy of blood collection processes through the integration of automated blood collection systems, reduced human errors, and patient discomfort. The growing emphasis on preventive healthcare is prompting an increased demand for regular blood tests, which are being utilized to monitor chronic conditions and ensure early diagnosis. According to American Diabetes Association, 38.4 million people have diabetes in the United States which is 11.6% of the U.S. population. The continuous trend toward minimally invasive blood collection, such as capillary blood collection and fingerstick technologies, is mainly driven by the increasing demand for personalized health care. Increasingly, health care providers are also investing in point-of-care testing solutions that enable quicker and more accessible blood collection in remote and underserved areas. Health-conscious consumers and increasing awareness of bloodborne diseases also enhance the demand for blood donation and testing services. Rising cases of chronic diseases such as diabetes, cardiovascular disease, and cancer are continually driving the need for blood tests in monitoring and controlling the progression of these diseases. Along with these, other factors such as improvement in equipment and consumables for collecting blood continue to influence the growth of the U.S. blood collection market.

ASIA PACIFIC BLOOD COLLECTION MARKET ANALYSIS

The blood collection market is growing in Asia Pacific due to investments in the healthcare infrastructure of emerging economies, such as India and China, which are developing medical facilities and diagnostic capabilities. Hospitals and diagnostic centers are also rapidly adopting automated blood collection devices, improving efficiency and reducing human error. The initiatives in the government area related to the betterment of the public health systems are also on an uptrend, which emphasizes that there should be a reasonable price and easy access to diagnostic services. With this growth in chronic diseases and with age, the elderly population, the demand for check-up on health and blood tests has increased. According to United Nations Population Fund (UNFPA), the elderly population is 153 million (aged 60 and above) in the year 2023 across India. Simultaneously, rising awareness about the importance of early disease detection is leading to greater patient participation in routine medical examinations. The growth of medical tourism, especially in countries like Thailand and Singapore, is also contributing to the expansion of the market, as international patients look for advanced diagnostic services. There is also a growing trend toward less invasive, safer, and more comfortable blood collection methods, which further drives the adoption of new technologies in the blood collection sector. These developments are collectively fueling the ongoing growth of the blood collection market in the Asia Pacific region.

EUROPE BLOOD COLLECTION MARKET ANALYSIS

The market for blood collection in Europe is showing growth, as healthcare service providers have become more focused on improving their capabilities to diagnose and ultimately improve patient outcomes. Improved technologies for blood collection, especially vacuum blood collection tubes, are being adopted by hospitals and diagnostic labs to make these processes much more streamlined and comfortable for patients. The demand for less invasive procedures is increasing, which directs the trend toward such products. An increased prevalence of chronic diseases like diabetes and cardiovascular diseases leads to increased blood test frequency, therefore propelling the market's growth. According to Eurostat, the number of in-patients with diseases of the circulatory system discharged from hospitals across the EU was 8.6 million in 2021. Additionally, healthcare regulations and the push for better patient safety are encouraging the use of safer, more reliable blood collection systems, reducing the risk of needle-stick injuries. Manufacturers are increasingly responding to a need for solutions that are bio-friendly, sustainable, biodegradable, or reusable blood collection products. Moreover, health and wellness among individuals in the region as well as the aging population are fuelling healthier preventive care outcomes, with an increase in demand for collecting blood services, governments are promoting public health infrastructures in the region. They further support research towards developing innovations in blood-collecting technologies, propelling growth within the regions.

LATIN AMERICA BLOOD COLLECTION MARKET ANALYSIS

The blood collection market in Latin America is currently expanding due to several specific factors. Healthcare providers are increasingly adopting advanced diagnostic technologies, which are driving the demand for high-quality blood collection devices. Regulatory bodies in countries like Brazil and Mexico are strengthening health standards and guidelines, ensuring more stringent requirements for blood collection and testing procedures. In addition, the ongoing efforts to improve healthcare infrastructure across the region are promoting the expansion of blood banks and diagnostic centers, contributing to higher demand for collection supplies. Growing awareness about early disease detection and preventive healthcare is further fuelling the need for blood tests. Urbanization is also playing a crucial role, with more people gaining access to healthcare services in metropolitan areas, thus driving the usage of blood collection products. According to the Brazilian Institute of Geography and Statistics, in 2019, Brazil had 45,945 km 2 of urbanized areas, the equivalent to 0.54% of the Brazilian area. Moreover, the rise in non-communicable diseases, such as diabetes and cardiovascular conditions, is prompting an increased frequency of medical checkups and blood tests, significantly boosting demand. Additionally, governments and non-profit organizations are investing in programs that focus on improving blood donation drives and transfusion services, which are directly enhancing the demand for blood collection tools in the region. These factors are collectively fuelling the growth of the blood collection market in Latin America.

MIDDLE EAST AND AFRICA BLOOD COLLECTION MARKET ANALYSIS

The blood collection market in the Middle East and Africa (MEA) is witnessing robust growth as healthcare systems are increasingly prioritizing blood donation and collection services. Governments and healthcare authorities are enhancing their focus on improving healthcare infrastructure, which is driving the demand for modernized blood collection systems. Additionally, hospitals and diagnostic centers are adopting automated blood collection technologies to improve efficiency and reduce errors, contributing to market growth. With rising awareness about blood donation campaigns and the critical need for blood during emergencies, the market is expanding as donors are being increasingly encouraged through awareness programs. Healthcare facilities are actively investing in advanced blood collection devices such as blood collection tubes, needles, and vacutainers to ensure safe and sterile processes. The spike in chronic diseases such as anemia, cancer, and diabetes are also driving the demand for regular blood tests and blood transfusions. According to the International Diabetes Federation, in 2021, 990,900 adults were affected with diabetes across UAE. Furthermore, the ongoing global health challenges, including the COVID-19 pandemic, are compelling governments and NGOs to focus on establishing more organized blood donation systems to support treatment needs. These developments are accelerating innovation in blood collection techniques, thus making blood collection more efficient and accessible across the MEA region.

COMPETITIVE LANDSCAPE:

The market is highly competitive, with key players emphasizing innovations focused on improving the efficiency and safety of blood collection processes. They are investing in research and development (R&D) activities to create advanced devices such as automated blood collection systems, minimally invasive tools, and needle-free technologies. Strategic partnerships and acquisitions are being pursued to expand product portfolios and reach untapped markets. Several companies are also focusing on sustainability by developing eco-friendly and disposable products to reduce medical waste. In addition to this, digital solutions such as data integration to track and manage blood samples better are being implemented by the leading companies. Apart from this, the players are also expanding their production capacities while conducting awareness campaigns and training programs to improve the adoption of modern blood collection techniques to meet the growing demand.

The report provides a comprehensive analysis of the competitive landscape in the keyword market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • FL MEDICAL s.r.l
  • Greiner AG
  • Haemonetics Corporation
  • McKesson Corporation
  • Medtronic plc
  • Nipro Corporation
  • Qiagen N.V.
  • Quest Diagnostics
  • Sarstedt AG & Co. KG
  • Terumo Corporation

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Collection Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Needles and Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Blood Collection Tubes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Serum-separating
      • 6.2.2.2 EDTA
      • 6.2.2.3 Heparin
      • 6.2.2.4 Plasma-separating
    • 6.2.3 Market Forecast
  • 6.3 Blood Bags
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Banks
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 FL MEDICAL s.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Greiner AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Haemonetics Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 McKesson Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Nipro Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sarstedt AG & Co. KG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Collection Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Collection Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Blood Collection Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Blood Collection Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Blood Collection Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Blood Collection Market: Breakup by End Use (in %), 2025
  • Figure 7: Global: Blood Collection Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Blood Collection (Needles and Syringes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Blood Collection (Needles and Syringes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Blood Collection (Blood Collection Tubes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Blood Collection (Blood Collection Tubes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Blood Collection (Blood Bags) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Blood Collection (Blood Bags) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Blood Collection (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Blood Collection (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Blood Collection (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Blood Collection (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Blood Collection (Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Blood Collection (Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Blood Collection (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Blood Collection (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Blood Collection (Diagnostics Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Blood Collection (Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Blood Collection (Blood Banks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Blood Collection (Blood Banks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Blood Collection (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Blood Collection (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Blood Collection Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Blood Collection Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Blood Collection Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Blood Collection Industry: SWOT Analysis
  • Figure 78: Global: Blood Collection Industry: Value Chain Analysis
  • Figure 79: Global: Blood Collection Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Collection Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Blood Collection Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Blood Collection Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Blood Collection Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Blood Collection Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Blood Collection Market: Competitive Structure
  • Table 7: Global: Blood Collection Market: Key Players